AAREYDRUGSAarey Drugs & PharmaceuticalsAAREYDRUGS info
$0.82info0.82%24h
Global rank29907
Market cap$20.79M
Change 7d-4.52%
YTD Performance29.64%
SP500 benchmarkOutperform
P/E0.55
P/S0.42
Revenue$49.22M
Earnings$449.54K
Dividend yield-
Main Sector
Healthcare

Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Stock Overview

Aarey Drugs & Pharmaceuticals Limited engages in the manufacture and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. The company was incorporated in 1990 and is headquartered in Mumbai, India.

AAREYDRUGS Stock Information

Symbol
AAREYDRUGS
Address
107, Sahakar BhavanMumbai, 400009India
Founded
-
Trading hours
-
Website
https://www.aareydrugs.com
Country
🇮🇳 India
Phone Number
91 22 2345 5543

Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Price Chart

-
Value:-

Aarey Drugs & Pharmaceuticals Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.8190970858335304
N/A
Market Cap
$20.79M
N/A
Shares Outstanding
25.39M
5.44%
Employees
0
N/A
Shareholder Equity
1.17B
3.32%
Valuation
2023
Change
P/E Ratio
0.55
N/A
P/S Ratio
0.42
N/A
P/B Ratio
0.02
N/A
Growth
2023
Change
Return on Equity
0.0004
N/A
Earnings
2023
Change
Revenue
$49.22M
N/A
Earnings
$449.54K
N/A
EPS
1.49
N/A
Earnings Yield
1.82
N/A
Gross Margin
0.0218
N/A
Operating Margin
0.0048
N/A
Net income margin
0.0091
N/A
Financial Strength
2023
Change
Total Assets
$34.73M
N/A
Total Debt
$4.50M
N/A
Cash on Hand
$133.97K
N/A
Debt to Equity
0.0177
27.98%
Cash to Debt
0.0298
-94.52%
Current Ratio
$1.61
-6.79%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org